Daniel Molloy-Brookes

Why supply chains matter in life sciences The life sciences sector relies on complex, interconnected supply chains to deliver medicines, diagnostics and medical technologies to patients. From raw materials and […]

Digital health at a turning point Digital health has moved from the margins of healthcare innovation to the centre of strategic planning across the UK. The growing use of digital […]

Originally by: Amy Grove, Professor of Implementation Science, University of Birmingham Read the original here: https://www.linkedin.com/pulse/from-proof-concept-impact-how-implementation-tc3le/?trackingId=5d7TGbesSN%2BEqMkIJFR7Vg%3D%3D How do we ensure that innovations developed in health, education or social care make […]

The government’s new 10 Year Health Plan, Fit for the Future, was published on 3 July 2025. Heralded as a bold statement of intent, it promises three radical shifts: hospital […]

Aston University has announced a major international partnership with Max Healthcare India, one of the country’s largest and most respected hospital networks. The two organisations have signed a memorandum of […]

The UK government’s renewed focus on data-driven innovation in the life sciences sector marks a major shift in how health research, diagnostics and treatment are delivered. Central to this transformation […]

A major pillar of the UK government’s new Life Sciences Sector Plan is a bold drive to boost domestic manufacturing of medical products, underpinned by a commitment of up to […]

The UK government has launched a new Life Sciences Sector Plan, a ten-year strategy designed to boost the country’s position as a global leader in life sciences. Announced on Wednesday […]

Joenja was approved by the MHRA in 2024 but was only issued to patients on the NHS for the first time in June.  What is APDS?  APDS (activated phosphoinositide 3-kinase […]

Researchers have found a way to absorb a toxic and long-lasting “forever chemical” which is often used in consumer goods.  Used in various consumer products  Products such as waterproof clothing, […]

In a landmark move that places the UK at the forefront of international health innovation, the country has become the first to join a new global network of regulators dedicated […]

An $11bn partnership between BioNTech and Bristol Myers Squibb has been signed. Potential competition to a leading drug The partnership involves the development of a cancer drug which could, potentially, […]

Medilink Midlands welcomed some of the region’s most innovative and interesting life sciences and health tech companies to their annual awards evening at the Grand Station in Wolverhampton on Thursday. […]